NASDAQ: DCGODocgo Inc Stock
$3.36+0.10 (+3.07%)
Updated Apr 17, 2024
DCGO Price
$3.36
Fair Value Price
$4.42
Market Cap
$350.02M
52 Week Low
$2.78
52 Week High
$10.82
P/E
48x
P/B
1.16x
P/S
0.93x
PEG
0.17x
Dividend Yield
N/A
Revenue
$624.29M
Earnings
$6.86M
Gross Margin
31.3%
Operating Margin
1.83%
Profit Margin
1.1%
Debt to Equity
0.62
Operating Cash Flow
-$64M
Beta
1.01
Next Earnings
May 6, 2024
Ex-Dividend
N/A
Next Dividend
N/A
DCGO Overview
DocGo, Inc. provides medical transportation services to health care providers in the U.S. and UK. Offerfings include ambulance services and wheelchair transportation services. It also offers mobile health services at homes and offices, COVID-19 testing, and on-site healthcare support at sporting events and concerts. DocGo was incorporated in 2015 and is headquartered in New York, NY.
Zen Score
–
Industry Average (30)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how DCGO scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
DCGO ($3.36) is undervalued by 24.05% relative to our estimate of its Fair Value price of $4.42 based on Discounted Cash Flow (DCF) modelling, but does not have a significant margin of safety
Below Fair Value Valuation
DCGO ($3.36) is significantly undervalued by 24.05% relative to our estimate of its Fair Value price of $4.42 based on Discounted Cash Flow (DCF) modelling, which includes a healthy margin of safety
Significantly Below Fair Value Valuation
DCGO ($3.36) is trading below... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
There are 30 more DCGO due diligence checks available for Premium users.
Be the first to know about important DCGO news, forecast changes, insider trades & much more!
DCGO News
Valuation
DCGO fair value
Fair Value of DCGO stock based on Discounted Cash Flow (DCF)
Price
$3.36
Fair Value
$4.42
Undervalued by
24.05%
DCGO ($3.36) is undervalued by... subscribe to Premium to read more.
Below Fair Value Valuation
DCGO ($3.36) is significantly undervalued... subscribe to Premium to read more.
Significantly Below Fair Value Valuation
DCGO ($3.36) is trading below... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
DCGO price to earnings (PE)
For valuing profitable companies with steady earnings
Company
48x
Industry
-2.51x
Market
41.64x
DCGO is good value based... subscribe to Premium to read more.
P/E vs Industry Valuation
DCGO is poor value based... subscribe to Premium to read more.
P/E vs Market Valuation
DCGO price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
1.16x
Industry
4.47x
DCGO is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation
DCGO price to earnings growth (PEG)
For valuing profitable companies with growth potential
DCGO is good value based... subscribe to Premium to read more.
PEG Value Valuation
DCGO's financial health
Profit margin
Revenue
$199.2M
Net Income
$7.6M
Profit Margin
3.8%
DCGO's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials
DCGO's profit margin has decreased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$490.5M
Liabilities
$185.3M
Debt to equity
0.62
DCGO's short-term assets ($338.87M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
DCGO's short-term assets ($338.87M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
DCGO's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
-$5.9M
Investing
-$3.0M
Financing
$13.0M
DCGO's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials
DCGO vs Medical Care Facility Stocks
Docgo Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.